SRx Health shares surge 31.15% premarket after redeeming Series A preferred stock and canceling 125M common shares.

SRx Health surged 31.15% in premarket trading following the announcement of redeeming all 17,418 shares of its Series A Convertible Preferred Stock for $21.8 million, coupled with the cancellation of approximately 125 million common shares. The move eliminates a significant convertible overhang, streamlining the company’s capital structure and signaling improved shareholder value alignment. By removing dilutive pressure and demonstrating financial discipline, the actions are viewed as a catalyst for investor confidence, directly supporting the sharp premarket rally.